{"id":44673,"date":"2021-04-05T11:29:41","date_gmt":"2021-04-05T08:29:41","guid":{"rendered":"https:\/\/vastuullisuusuutiset.fi\/?p=44673"},"modified":"2021-04-05T11:32:58","modified_gmt":"2021-04-05T08:32:58","slug":"how-can-we-vaccinate-the-world-five-challenges-facing-the-un-backed-covax-programme","status":"publish","type":"post","link":"https:\/\/vastuullisuusuutiset.fi\/en\/chief-editors-choice\/how-can-we-vaccinate-the-world-five-challenges-facing-the-un-backed-covax-programme\/","title":{"rendered":"How can we vaccinate the world? Five challenges facing the UN-backed COVAX programme"},"content":{"rendered":"<div class=\"smart_content_wrapper\"><p>The aim of the UN-backed COVAX scheme is to get two billion vaccine doses into the arms of around a quarter of the population of poorer countries by the end of 2021. What are the main challenges that need to be overcome, if this historic global effort is to be achieved?<\/p>\n<p>Vaccines are a key part of the solution to ending the COVID-19 pandemic and, since the early stages of the crisis, the World Health Organization (WHO) has argued that there needed to be coordinated attention given to ensuring that everyone, not just people living in rich countries, would receive adequate protection from the virus, as it spread rapidly across the world. Out of this concern grew the Global COVAX Facility, the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both higher-income and lower-income countries.<\/p>\n<p>Here are five things to know about the challenges facing COVAX, and how they can be overcome.<\/p>\n<p>1) Export controls: the weakest link?<br \/>\nEarly on in the pandemic, UNICEF built up a stockpile of half a billion syringes in warehouses outside the countries producing them. Its foresight paid off: countries put export controls on syringes, prices spiked, and supplies were limited.<\/p>\n<p>2) Getting vaccines to those who need it is not easy<br \/>\nWhilst all of the countries that are part of COVAX have the infrastructure needed to get pallets of vaccines off cargo planes and into refrigerated warehouses, the next steps can be more complicated.<\/p>\n<p>3) More funding is needed to help rollout in the poorest countries<br \/>\nOne way to speed up the vaccine rollout, and the delivery from urban warehouses to remote areas is, quite simply, cash.\u00a0Contributions from several countries, particularly the EU, the UK and the US have gone a long way to closing the vaccine funding gap. However, funding for the delivery of those vaccines is more problematic.<\/p>\n<p>4) Richer countries should share<br \/>\nCOVAX is finding itself in competition with individual countries doing direct deals with pharmaceutical companies, putting extra pressure on the available supply of COVID-19 vaccines. At the same time, richer countries may find themselves with an over-supply of doses.<\/p>\n<p>5) Vaccine hesitancy: a continued cause for concern<br \/>\nDespite the overwhelming evidence that vaccination saves lives, vaccine hesitancy, which exists in every country, is still a problem that needs to be constantly addressed.<\/p>\n<p>Source: <a href=\"https:\/\/news.un.org\/en\/story\/2021\/04\/1088932\">The UN<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The aim of the UN-backed COVAX scheme is to get two billion vaccine doses into the arms of around a quarter of the population of&#8230;<\/p>","protected":false},"author":4,"featured_media":28310,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":null,"_FSMCFIC_featured_image_hide":null,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[5594],"tags":[10192,383,8956],"class_list":["post-44673","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-chief-editors-choice","tag-the-world","tag-un","tag-vaccination","wpcat-5594-id"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/vastuullisuusuutiset.fi\/wp-content\/uploads\/2020\/10\/rokote_uusi1.jpg?fit=100%2C100&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/posts\/44673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/comments?post=44673"}],"version-history":[{"count":1,"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/posts\/44673\/revisions"}],"predecessor-version":[{"id":44674,"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/posts\/44673\/revisions\/44674"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/media\/28310"}],"wp:attachment":[{"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/media?parent=44673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/categories?post=44673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vastuullisuusuutiset.fi\/en\/wp-json\/wp\/v2\/tags?post=44673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}